Clinical Trial Update: Intensity-modulated Radiotherapy With Integrated-boost in Patients With Spinal Bone Metastases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of intensity-modulated radiotherapy with an integrated boost in patients with spinal bone metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases
• Spinal Metastases

Snippet

Sponsor: Heidelberg University | Conditions: Vertebral Bony Metastases | Phase 2 | Status: UNKNOWN